Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
13.77
+0.37 (2.76%)
Aug 13, 2025, 4:00 PM - Market closed
Avadel Pharmaceuticals Employees
Avadel Pharmaceuticals had 188 employees as of December 31, 2024. The number of employees increased by 34 or 22.08% compared to the previous year.
Employees
188
Change (1Y)
34
Growth (1Y)
22.08%
Revenue / Employee
$1,175,931
Profits / Employee
-$15,548
Market Cap
1.34B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AVDL News
- 6 days ago - Avadel Pharmaceuticals plc (AVDL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 days ago - Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance - GlobeNewsWire
- 14 days ago - Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7 - GlobeNewsWire
- 4 weeks ago - ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders - Business Wire
- 6 weeks ago - ASL pushes for board shakeup at Avadel over handling of sleep drug rollout - Reuters
- 6 weeks ago - Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation - GlobeNewsWire
- 6 weeks ago - ASL Strategic Value Fund targets Avadel board over Lumryz drug mismanagement, WSJ reports - Reuters